hello pharmacist bpc 157 BPC-157 for Foot Pain BPC-157: Experimental Peptide Creates Risk
Description
Compounded medications are not FDA-approved, but are prepared by licensed compounding pharmacies
FDA is proposing that all 7 peptides be rejected from the 503A compounding list
doi:10.1016/j.ajog.2012.08.035 Gomes M, Trocado V, Carlos-Alves M, Arteiro D, Pinheiro P
ONIVYDE is not given alone
